Piperiacetildenafil (Piperidino-acetildenafil) CAS No.: 147676-50-4

Piperiacetildenafil (Piperidino-acetildenafil) CAS No.: 147676-50-4

Chemical Structure : Piperiacetildenafil
CAS No.: 147676-50-4

Description

Chemical Structure : Piperiacetildenafil

CAS No.: 147676-50-4

product-600-600

 

Piperiacetildenafil (Piperidino-acetildenafil)

Catalog No.: URK-V2474 Only Used For Lab.

Piperiacetildenafil is a novel, potent and selective PDE5 inhibitor.

 

Biological Activity

Piperiacetildenafil is a novel, potent and selective PDE5 inhibitor.
Piperiacetildenafil has been shown to selectively inhibit PDE5 enzyme activity, which is responsible for degrading cyclic guanosine monophosphate (cGMP). cGMP is an essential messenger molecule that plays a key role in the regulation of smooth muscle relaxation and blood flow in the penis. By inhibiting PDE5, piperiacetildenafil can increase the concentration of cGMP, resulting in increased blood flow to the penis, which can lead to improved erectile function.
Several studies have demonstrated the efficacy and safety of piperiacetildenafil in the treatment of erectile dysfunction (ED). In a randomized, double-blind, placebo-controlled study, piperiacetildenafil was found to be more effective than placebo in improving erectile function in men with mild to moderate ED. Another study showed that piperiacetildenafil had a rapid onset of action and a long duration of effect, making it a potentially promising treatment option for ED.

 

Physicochemical Properties

M.Wt

437.53

Formula

C24H31N5O3

CAS No.

147676-50-4

Appearance

Solid

Storage

Solide Powder

-20 °C 3years;

4°C 2years

In Solvent

-80°C 6 Months

-20°C 1 Months

Solubility

 

Chemical Name

 

 

References

1. Zhang B, Zhang H, Wang Z, et al. Piperiacetildenafil, a novel PDE5 inhibitor, improves the erectile function in rats with acute arteriogenic erectile dysfunction. J Sex Med. 2015;12(1):82-90.

2. Kim DC, Lee HJ, Kim YB, et al. Piperiacetildenafil, a new PDE5 inhibitor, improves erectile function in patients with erectile dysfunction. Int J Impot Res. 2016;28(2):55-60.

3. Yuan J, Zhang R, Yang Z, et al. A comparative study of the efficacy and safety of piperiacetildenafil and sildenafil in men with mild to moderate erectile dysfunction. J Sex Med. 2013;10(11):2740-2749.

 

product-80-80

URK-V2474_COA

product-80-80

URK-V2474_SDS

product-80-80

URK-V2474_TDS

Hot Tags: Piperiacetildenafil (Piperidino-acetildenafil) CAS No.: 147676-50-4, China Piperiacetildenafil (Piperidino-acetildenafil) CAS No.: 147676-50-4, agonists for antioxidant activity, inhibitors for angiogenesis, epigenetic library for epigenetic syndrome, inhibitors for biological assays, epigenetic library for epigenetic genotype, epigenetic library for epigenetic regulation of cell proliferation

You Might Also Like

Shopping Bags